A Bio-equivalence Study of Sofosbuvir From Magicbuvir 400 mg Film Coated Tablets ( Magic Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)

NCT02953535 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Magicbuvir
DRUG: Sovaldi (fist dose)
DRUG: Sovaldi (second dose)

Sponsor

Genuine Research Center, Egypt

Collaborators

[object Object]